Skip to content

The effect of weight loss (bariatric surgery or diet therapy with exercise) on migraine charchteristics in obese patients with migraine headaches who referred to Sina hospital weight loss clinic

A study of migraine improvement after diet/exercise-induced weight loss or bariatric surgery in patients with chronic migraine who presents to Sina hospital weight-loss clinic

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201612069157N2
Enrollment
54
Registered
2016-12-26
Start date
2016-05-02
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraine headache. Migraine, unspecified

Interventions

Treatment - Surgery
Lifestyle
Intervention 1: Bariatric Surgery This trial will be conducted on morbid obese patients referred to Sina hospital weight loss clinic after obtaining a written consent. According to the guidelines in
Bariatric Surgery This trial will be conducted on morbid obese patients referred to Sina hospital weight loss clinic after obtaining a written consent. According to the guidelines in the treatment o
Diet therapy and exerciseobese patients who suffered from migraine and having a BMI level between 35 to 39.9 as well as morbid obese patients who are not willing to undergo for the surgery, will be tr

Sponsors

Iranian Center of Neurological Research, Tehran University of Medical Sciences,
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: having more than 15 headache days per month for at least 3 months; avoiding the use of migraine prophylactic drugs in the last 4 weeks; lack of advanced disease including kidney, heart and liver disease; the absence of major depression and psychotic disorders suffering from morbid obesity (BMI 35 range to 39/9 with co-morbidities or BMI> =40). Exclusion criteria: lack of adherence to diet and exercise to more than 70%; taking Migraine prophylactic drugs; suffering from chronic kidney disease, heart and liver diseases, major depression and psychosis; pregnancy and unwillingness to cooperate in the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Migraine severity. Timepoint: Baseline, one month and 6 months after the intervention. Method of measurement: Visual Analog Scale (VAS).;Migraine headache duration. Timepoint: Baseline, one month and 6 months after the intervention. Method of measurement: Migraine headache diary.;Migraine headache frequency. Timepoint: Baseline, one month and 6 months after the intervention. Method of measurement: Migraine headache diary.

Secondary

MeasureTime frame
Amount of weight reduction. Timepoint: Baseline, 1 and 6 months after the intervention. Method of measurement: Weight scale.;Body fat percentage. Timepoint: Baseline, 1 and 6 months after the intervention. Method of measurement: BIA.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactProf. Mansoureh Togha

Iranian Center of Neurological Research, Tehran University of Medical Sciences

toghae@sina.tums.ac.ir+98 21 6670 2052

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026